Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -33.85% is 176% below its 5-year average of -12.28%, near the low end of its 5-year range (-37.92%–-0.34%).
19.17% below its 12-month average of -28.41%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -1.09%.
RETURN ON ASSETS (ROA)
-33.85%
RETURN ON ASSETS (ROA) AVG TTM
-28.41%
RETURN ON ASSETS (ROA) AVG 3Y
-17.06%
RETURN ON ASSETS (ROA) AVG 5Y
-12.28%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-19.17%
CURRENT VS 3Y AVG
-98.45%
CURRENT VS 5Y AVG
-175.61%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.07%
median of 569 covered companies
CURRENT VS SECTOR MEDIAN
-20.59%
vs the sector median at left
Definitive Healthcare Corp.
Market Cap
$105.15M
Return on Assets (ROA)
-33.85%
TTM Avg
-28.41%
3Y Avg
-17.06%
5Y Avg
-12.28%
Market Cap
$105.61M
Return on Assets (ROA)
-80.25%
TTM Avg
-36.24%
3Y Avg
-78.62%
5Y Avg
-77.58%
Market Cap
$106.83M
Return on Assets (ROA)
-16.87%
TTM Avg
-6.13%
3Y Avg
-6.48%
5Y Avg
-5.59%
Market Cap
$107.45M
Return on Assets (ROA)
-34.04%
TTM Avg
-20.59%
3Y Avg
-37.88%
5Y Avg
-37.10%
Market Cap
$102.00M
Return on Assets (ROA)
7.36%
TTM Avg
-1.10%
3Y Avg
-3.18%
5Y Avg
2.66%
Market Cap
$106.73M
Return on Assets (ROA)
-70.09%
TTM Avg
-324.97%
3Y Avg
-229.15%
5Y Avg
-168.27%
Market Cap
$108.33M
Return on Assets (ROA)
-31.75%
TTM Avg
-34.00%
3Y Avg
-32.33%
5Y Avg
-29.29%
Market Cap
$109.64M
Return on Assets (ROA)
-85.80%
TTM Avg
-37.85%
3Y Avg
-56.27%
5Y Avg
-56.27%
Market Cap
$109.91M
Return on Assets (ROA)
-14.14%
TTM Avg
-26.48%
3Y Avg
-30.34%
5Y Avg
-26.58%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Definitive Healthcare Corp. (DH) | $105.15M | -33.85% | -28.41% | -17.06% | -12.28% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $105.61M | -80.25% | -36.24% | -78.62% | -77.58% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.83M | -16.87% | -6.13% | -6.48% | -5.59% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $107.45M | -34.04% | -20.59% | -37.88% | -37.10% |
| The Joint Corp. (JYNT)vs › | $102.00M | 7.36% | -1.10% | -3.18% | 2.66% |
| Immunic, Inc. (IMUX)vs › | $106.73M | -70.09% | -324.97% | -229.15% | -168.27% |
| Foghorn Therapeutics Inc. (FHTX)vs › | $108.33M | -31.75% | -34.00% | -32.33% | -29.29% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $109.64M | -85.80% | -37.85% | -56.27% | -56.27% |
| Apyx Medical Corporation (APYX)vs › | $109.91M | -14.14% | -26.48% | -30.34% | -26.58% |
| BGM Group Ltd. (BGM)vs › | $112.03M | -4.60% | -3.66% | -5.21% | -1.02% |
ROA
-33.9%
ROE
-116.3%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -18.89% |
| 2024-12-31 | -37.92% |
| 2023-12-31 | -11.08% |
| 2022-12-31 | -0.34% |
| 2021-12-31 | -2.45% |
| 2020-12-31 | -3.01% |
| 2019-12-31 | -2.11% |
